U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07532577) titled 'Intranasal Insulin to Prevent Intensive Care Unit Delirium' on April 02.
Brief Summary: This study aims to assess the feasibility, tolerability, and exploratory efficacy of intranasal insulin to prevent delirium in ICU patients aged >=65 years after complex elective cardiac surgery with cardiopulmonary bypass
Study Start Date: April 15
Study Type: INTERVENTIONAL
Condition:
Delirium - Postoperative
Intervention:
DRUG: Intranasal insulin-40U
Intranasal isophane insulin administered twice daily. Each administration consists of two sprays of 10 IU (0.1 ml) in alternating nostrils, totalling to 40 IU per day.
DRUG: Intranasal so...